Financial Performance - The company's operating revenue for Q1 2025 was ¥31,672,994.67, a decrease of 32.04% compared to ¥46,603,068.17 in the same period last year[4] - The net profit attributable to shareholders was a loss of ¥7,068,804.09, improving from a loss of ¥15,019,069.20 year-on-year[4] - The net cash flow from operating activities was negative at ¥16,763,668.30, compared to negative ¥14,639,831.57 in the previous year[4] - The weighted average return on net assets was -1.86%, an improvement from -3.51% in the previous year[4] - The company reported a non-recurring gain of ¥2,593,354.03, primarily from asset impairment reversals and government subsidies[6] - Net profit for Q1 2025 was -¥6,638,309.13, an improvement from -¥16,406,836.05 in Q1 2024[20] - The company reported a basic and diluted earnings per share of -¥0.10 for Q1 2025, an improvement from -¥0.21 in Q1 2024[20] Research and Development - Total R&D investment amounted to ¥6,799,026.04, down 40.58% from ¥11,443,082.59, with R&D expenses accounting for 21.47% of operating revenue, a decrease of 3.08 percentage points[5] - The company is optimizing its R&D resource allocation, leading to a reduction in R&D expenses during the reporting period[8] - Research and development expenses for Q1 2025 were ¥6,799,026.04, down 40.0% from ¥11,443,082.59 in Q1 2024[19] - Research and development expenses for Q1 2025 were CNY 6,836,921.24, down from CNY 9,049,773.87 in Q1 2024, indicating a focus on cost management[29] Assets and Liabilities - Total assets at the end of the reporting period were ¥846,422,004.01, a decrease of 3.50% from ¥877,113,959.73 at the end of the previous year[5] - Total current assets decreased from 325,062,241.39 RMB at the end of 2024 to 289,308,963.73 RMB as of March 31, 2025, a decline of approximately 11%[13][15] - Total liabilities decreased to ¥492,170,331.13 in the latest report from ¥514,994,750.62[16] - Total equity attributable to shareholders decreased to ¥375,983,865.55 from ¥384,281,896.74[16] - The total assets decreased to CNY 814,766,255.71 as of March 31, 2025, from CNY 846,622,216.97 at the end of 2024[28] - The total liabilities decreased to CNY 326,629,885.82 as of March 31, 2025, from CNY 350,802,558.30 at the end of 2024[28] Shareholder Information - Total number of common shareholders at the end of the reporting period is 2,386[10] - The largest shareholder, Zhou Zhen, holds 14,609,675 shares, representing 20.87% of total shares[10] - There are no significant changes in the top 10 shareholders or their shareholding status compared to the previous period[11] Operational Strategy - The company adjusted its operational strategy in response to market conditions, focusing on efficiency improvements and cost reductions[8] - The decline in revenue was attributed to market adjustments and a slowdown in downstream investment and demand[8] Cash Flow - Cash received from sales and services in Q1 2025 was ¥28,328,686.18, down 47.9% from ¥54,381,714.21 in Q1 2024[22] - Cash outflow from investment activities for Q1 2025 was -¥10,288,291.19, compared to -¥36,310,352.40 in Q1 2024[23] - The company's cash flow from financing activities showed a net cash inflow of CNY 16,022,563.51 in Q1 2025, slightly down from CNY 16,442,148.40 in Q1 2024[24] - The net cash flow from investing activities was -$2.08 million in Q1 2025, compared to -$5.62 million in Q1 2024, indicating improved cash management[32] - The total cash inflow from investment activities in Q1 2025 was $2,650, a sharp decline from $16.22 million in Q1 2024[32]
禾信仪器(688622) - 2025 Q1 - 季度财报